Anika Therapeutics | Brutto Fortjeneste På Salg

Gross Profit On Sales Endring Dato
Agios Pharmaceuticals USD 6.52M 249K 2023-12
Halozyme Therapeutics USD 177.74M 16.53M 2023-12
Insmed USD 65.25M 2.88M 2023-12
Integra LifeSciences USD 239.24M 14.93M 2023-12
Ligand Pharmaceuticals USD 26.46M 2.92M 2023-12
Merit Medical Systems USD 142.2M 10.58M 2023-09
Smith & Nephew USD 1.9B 50M 2023-06
Stryker USD 3.71B 535M 2023-12
Veracyte USD 68.82M 6.32M 2023-12
Zimmer Biomet Holdings USD 1.4B 166.3M 2023-12



Anika Therapeutics Brutto Fortjeneste På Salg - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2024.